Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Annual Report 2002 - Essential Drugs and Medicines Policy: Supporting Countries to Close the Access Gap
(2003; 20 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentDeveloping a monitoring culture to improve impact
View the documentTraditional and complementary medicine: putting policy into action
View the documentKey country support in Africa and Eastern Mediterranean
View the documentWHO Collaborating Centres: supplying active support for medicines work
View the documentHow is TRIPS affecting access to medicines?
View the documentDevelopment of the essential drugs concept over the past 25 years
View the documentMeasuring access to antimalarials
View the documentStrengthening regional and national bulk procurement
View the documentLearning from successful supply systems
View the documentWorking out the cost of medicines
View the documentSupporting MDG target on access to essential medicines
View the documentCommon guideline for evaluating new medicines in Baltic countries
View the documentNGO toolkit for improving access to HIV/AIDS treatment
View the documentHarmonizing medicines regulation in the Americas
View the documentGood manufacturing practice in China: rapid progress
View the documentPharmacovigilance: detecting and reporting adverse drug reactions
View the documentVariations in prescribing information in 26 countries
View the document10th ICDRA: an international basis for medicines regulation
View the documentFighting poor-quality drugs
View the documentImproving medicines use in hospitals in Cambodia and Lao PDR
View the documentWHO-India Essential Drugs Programme: multiplying impact
View the documentOman: improving antibiotic use in primary health care
 

Supporting MDG target on access to essential medicines

The Millennium Development Goals (MDG) are an ambitious agenda for reducing poverty and improving lives that world leaders agreed on at the Millennium Summit in September 2000. For each goal one or more targets have been set - most for 2015, using 1990 as a benchmark. MDG target 17 is, “In co-operation with pharmaceutical companies, provide access to affordable essential drugs in developing countries” and the indicator for monitoring progress is “the proportion of population with access to affordable essential drugs on a sustainable basis”.

WHO's engagement to achieve the MDG access target involves four components. Helping countries achieve better prices is pursued through price information services and technical assistance on effective price regulation, as well as by enlarging the supplier base for essential drugs. Careful selection is supported through the Model List of Essential Medicines process, and its use at country and health facility level. Better medicine supply systems are supported by procurement information and advice. Strategies to raise and improve the fairness of medicines financing include providing guidance and technical support for ensuring subsidies for key medicines for poor people, and inclusion of drugs in expanded health insurance schemes.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014